title: Treating obesity in older adults: different risks, different goals, different strategies.
abstract: Almost 70% of adults 60 years of age and older are overweight according to the National Health and Nutrition Examination Survey 2005-2006. While being overweight is linked to numerous comorbidities and functional impairment, few studies have addressed obesity in elders, and even fewer have addressed sarcopenic obesity. Elder obesity requires different strategies, partly because most approved weight-reduction agents and/or surgical interventions are contraindicated in older adults. Strategies and objectives for weight loss are discussed along with the consultant pharmacist's role.
authors.affiliation: National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Guido R
authors.initials: GR
authors.lastname: Zanni
authors.forename: Jeannette Y
authors.initials: JY
authors.lastname: Wick
mesh_terms: D000367:Age Factors; D000368:Aged; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D003253:Consultants; D000075202:Contraindications; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology / Q000628:therapy*; D010595:Pharmacists / Q000458:organization & administration; D024382:Professional Role; D055948:Sarcopenia / Q000150:complications*; D015431:Weight Loss
chemical_list: D019440:Anti-Obesity Agents